Updated 08:05 GMT, 20 Nov 2026 SPX 7,175.83 -2.02% NDX 26,517.05 -2.21% VIX 28.44 +15.80% GOLD 3,574.90 -3.00% CL 82.63 -0.70% BTC 61,735.58 -0.27%
NAS100 26,517 −2.21% S&P 7,176 −2.02% GOLD $3,575 −3.00% BTC $61,736 −0.27% VIX 28.44 +15.80% latest tape · as of 08:05 UTC
The Screen · Energy · Oil & Gas Refining & Marketing

Phillips 66 logoPhillips 66

PSX · a US exchange · USD · Market cap $97.8B · 12,600 employees

Phillips 66 operates as an integrated downstream energy provider in the United States, the United Kingdom, Germany, and internationally.

PASS · Titan Ethical · score 79.9
242.71 USD

Price as of 19 Nov 2026Daily close, not a live quote

Screened 2026-11-19 · the tape above runs as of 08:05 UTC · two dates, stated on purpose · verdict and workings shown in full · never trimmed

Key facts today

  • Price242.71 USD at the 19 Nov 2026 close
  • Our value readUndervalued vs our fair value, as of 19 Nov 2026
  • Our regime readDistribution, as of 17 Nov 2026
  • Ethical screenPasses, score 79.9 out of 100
  • OptionsOpen interest leans to puts (put/call 2.93)
  • Last reviewed19 Nov 2026 (1 day ago)
  • Release timesRelease and earnings times on your chart: Event Guard Mentor

A summary of the dated readings below, not a live quote and not advice.

PRICE · ONE YEAR

Our fair-value range: $204.56 to $340.94, base estimate $284.88 (screen dated 2026-11-19).

Current read
Distribution ?
Undervalued · screened 2026-11-19
  • Trend Distribution
  • Insiders no filings inside 60 days, left as found
  • Positioning no disclosures inside 60 days, left as found
  • Options put/call open interest 2.93, read 2026-11-19
  • Ethical passes the values gate
Price242.71 USD
Fair value284.88
Ethical score79.9/100
Value readUndervaluedas of 19 Nov 2026
Our investment reviews on this name
2026-11-11Read Distribution250.70-3.2% to today ✓Markup gives way to Distribution after an 8% slide in 7 days
2026-11-04Read Markup271.94-10.7% to today Accumulation gives way to Markup after a 13% rise in 10 weeks
2026-08-25Read Accumulation240.00+1.1% to today ✓Markup gives way to Accumulation after a 31% rise in 8 weeks
2026-07-02Read Markup183.08+32.6% to today ✓First review on file: Markup

Our analytic regime reads on this name, dated and marked against the screened price. Small sample per name, and separate from the daily-framework accuracy on the Track Record page.

The full research record, in depth, below
The Label · The Season, Not the Day

This name holds its distribution label.

Phillips 66 holds its Distribution at $242.71. The statistical read favours the sellers, held for 4 days.

As held on the ledger · 2026-11-19
PhaseDistribution · caution
Quantitative stateThe statistical read favours the sellers, held for 4 days
Price at the screen$242.71
Valuation8.04 trailing · 7.77 forward price to earnings
Values screenPASS · score 79.9
Beta0.67
The Workings

Five Screens: PSX's Results

PASS. All five recorded results clear their limits.

TestFigureLimitStatus
Business activity Permissible Permissible core business Pass
Debt load 26.76% Below 33% Pass
Interest-bearing cash 15.75% Below 33% Pass
Receivables 14.78% Below 49% Pass
Revenue purity 0.11% Below 5% Pass

Definitions, sources and threshold rules: ticker values-screen methodology.

The Ethical Read

Why It Clears, in Plain English

Phillips 66 clears all five screens. Its business is in a permissible area, its interest-bearing debt is about 27%, inside the ~33% line, and almost none of its income is interest, so it passes.

Read as at 2026-11-19. It updates when the underlying figures move, and past reads are kept below.

Follow this verdict

Get an email when PSX's ethical verdict changes

Today PSX passes the screen. If new figures move it to a fail, we send you one short email with the before and after. Verdicts change rarely, so you may not hear from us for a long time.

Free, no account needed. Every email has a link to stop.

What the Numbers Say It Is Worth

The Fair Value Range

Our analysis reads Undervalued vs our fair value, as of 19 Nov 2026: it trades at roughly a 15% discount to our $284.88 fair value, weak competitive moat, 46.40% revenue growth.

Model construction and limits: fair-value methodology.

204.56Conservative284.88Base case340.94Growth case 242.71Price

Fair value range in USD, drawn from the 2026-11-19 screen. The gold marker is the market price at the same screen. A 14.8% discount to the base estimate.

The Street's Range
188.00Street low 297.00Street average 350.00Street high 242.71Price

Third-party analyst targets: 19 covering, consensus Buy. The average target sits +22% from the screen price.

Reading the gap · Both our model and the analysts see meaningful upside from here.

Price History & Projections

Where our models see it going: fair-value estimate $284.88, with a range of $204.56 to $340.94, dated to the 2026-11-19 screen.

How our estimate and third-party targets differ.

The Business, in Plain Words

Refining margins look tempting until they vanish

Picture a petrol station forecourt where pump prices swing with every tanker that docks. Phillips 66 sits right in that chain, turning crude into fuel and chemicals across five segments. It trades at 11.5 times forward earnings with 7 percent revenue growth and 15 percent ROE, numbers that appear attractive on the surface.

The business passes our ethical screen and draws buy ratings from most analysts. Yet refining is a classic cyclical activity where earnings peak just as multiples compress. A weak moat and 3 percent profit margin leave little cushion when demand or feedstock costs turn.

Our fair value sits 14 percent below the current price. That gap, combined with the risk of peak-cycle earnings, points to a value trap rather than a bargain. Analysis, not advice.

The fundamentals · plain-English read
Forward P/E7.8xcheap for a company growing this fast
Trailing P/E8.0xvery cheap relative to earnings
EPS, trailing31.18
EPS, forward32.28
Revenue growth+46.4%growing very fast
Profit margin7.5%thin but positive margins
Return on equity39.8%an exceptional return on shareholder capital
FCF yield9.73%
Dividend yield2.07%
Debt to equity0.52moderate, manageable leverage
Current ratio1.34adequate liquidity, worth monitoring
Beta0.67steadier than the market
Short interest, float0.02%
52-week range127.16 - 299.39
MoatWEAK
Market cap$97.8B
Employees12,600

Metric definitions and interpretation rules: ticker-page methodology.

The Dated Journal · Newest First, Never Edited

Every Entry, As Written

2026-11-18 Distribution $256.93 +2.5% Entry 24

The analysis reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved up 2.5% since our last review. Ethical screening: PASS with strong ethical credentials. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is holding around 22% above its long-term trend line with momentum reading oversold. Over the past year the shares are up 59%. Our forward projection puts the odds of a 10% gain over the next month near 23%. The street (19 analysts) rates it buy, with a mean price target of $187.

2026-11-11 Distribution · changed $250.70 -7.8% Entry 23

The framework has shifted from markup to distribution since the last review. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 7.8% since our last review. Ethical screening: PASS with strong ethical credentials. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is holding around 22% above its long-term trend line with momentum reading oversold. Over the past year the shares are up 59%. Our forward projection puts the odds of a 10% gain over the next month near 23%. The street (19 analysts) rates it buy, with a mean price target of $187. Since the last review it its composite score rose.

2026-11-04 Markup · changed $271.94 -6.0% Entry 22

The framework has shifted from accumulation to markup since the last review. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 6.0% since our last review. Ethical screening: PASS with strong ethical credentials. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it A, carrying a low risk profile. Technically it is holding around 45% above its long-term trend line with momentum reading bullish. Over the past year the shares are up 59%. Our forward projection puts the odds of a 10% gain over the next month near 23%. The street (19 analysts) rates it buy, with a mean price target of $187.

2026-10-28 Accumulation $289.20 +0.0% Entry 21

The analysis reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 0.0% since our last review. Ethical screening: PASS with strong ethical credentials. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is holding around 45% above its long-term trend line with momentum reading bullish. Over the past year the shares are up 59%. Our forward projection puts the odds of a 10% gain over the next month near 23%. The street (19 analysts) rates it buy, with a mean price target of $187. It reported earnings in this window, a natural checkpoint for the thesis.

2026-10-27 Accumulation $289.20 +0.0% Entry 20

The analysis reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 0.0% since our last review. Ethical screening: PASS with strong ethical credentials. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is holding around 45% above its long-term trend line with momentum reading bullish. Over the past year the shares are up 59%. Our forward projection puts the odds of a 10% gain over the next month near 23%. The street (19 analysts) rates it buy, with a mean price target of $187. It reported earnings in this window, a natural checkpoint for the thesis.

2026-10-26 Accumulation $289.20 +0.0% Entry 19

The analysis reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 0.0% since our last review. Ethical screening: PASS with strong ethical credentials. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is holding around 45% above its long-term trend line with momentum reading bullish. Over the past year the shares are up 59%. Our forward projection puts the odds of a 10% gain over the next month near 23%. The street (19 analysts) rates it buy, with a mean price target of $187. It reported earnings in this window, a natural checkpoint for the thesis.

2026-10-25 Accumulation $289.20 +0.0% Entry 18

The analysis reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 0.0% since our last review. Ethical screening: PASS with strong ethical credentials. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is holding around 54% above its long-term trend line with momentum reading overbought. Over the past year the shares are up 59%. Our forward projection puts the odds of a 10% gain over the next month near 23%. The street (19 analysts) rates it buy, with a mean price target of $187. It reported earnings in this window, a natural checkpoint for the thesis.

2026-10-24 Accumulation $289.20 +0.0% Entry 17

The analysis reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 0.0% since our last review. Ethical screening: PASS with strong ethical credentials. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is holding around 54% above its long-term trend line with momentum reading overbought. Over the past year the shares are up 59%. Our forward projection puts the odds of a 10% gain over the next month near 23%. The street (19 analysts) rates it buy, with a mean price target of $187. It reported earnings in this window, a natural checkpoint for the thesis.

2026-10-23 Accumulation $289.20 +0.0% Entry 16

The analysis reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 0.0% since our last review. Ethical screening: PASS with strong ethical credentials. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it A, carrying a low risk profile. Technically it is holding around 54% above its long-term trend line with momentum reading overbought. Over the past year the shares are up 59%. Our forward projection puts the odds of a 10% gain over the next month near 23%. The street (19 analysts) rates it buy, with a mean price target of $187. It reported earnings in this window, a natural checkpoint for the thesis.

2026-10-22 Accumulation $289.20 +0.0% Entry 15

The analysis reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 0.0% since our last review. Ethical screening: PASS with strong ethical credentials. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is holding around 54% above its long-term trend line with momentum reading overbought. Over the past year the shares are up 59%. Our forward projection puts the odds of a 10% gain over the next month near 23%. The street (19 analysts) rates it buy, with a mean price target of $187. It reported earnings in this window, a natural checkpoint for the thesis.

Each entry above was written on its date, before the outcome. A journal you can prune is not a journal.

Latest News · What the Market Is Reading on PSX

Headlines from third-party outlets, linked for reference: not our reporting, not advice.

Related Securities · Others in PSX's Space

Screened names in the same industry · explore each on its own page.

The Insider Ledger · Form 4 Filings, As Filed
Most recent filings · PSX
DateInsiderTitleTypeSharesValue
2026-09-16 Mandell Brian EVP S - Sale+OE 23,400 $6,202,381
2026-05-11 MITCHELL KEVIN J Chief Financial Officer 30,000 $5,101,083
2026-05-11 MITCHELL KEVIN J Chief Financial Officer 30,000 $2,848,390
2026-05-06 MEYERS KEVIN OMAR Director 175 $30,297
2026-03-30 MITCHELL KEVIN J Chief Financial Officer 15,629 $2,970,546
2026-03-30 MITCHELL KEVIN J Chief Financial Officer 15,629 $1,484,247
2026-03-17 MEYERS KEVIN OMAR Director 175 $30,310
2026-03-16 UNGERLEIDER HOWARD I. Director 949 $164,023
2026-03-16 MEYERS KEVIN OMAR Director 949 $164,023
2026-03-13 DAVIS LISA ANN Director 3,800 $662,617

Public filings, recorded as found. The full tape lives at Insider Intelligence.

What Holding Actually Paid · Price Plus Dividends
If $1,000 had been placed · historical, not a promise
PeriodPrice thenPrice returnDivs per share$1,000 becameTotal return
1 month $174.10 +4.6% $1.27 $1,053 +5.3%
2 months $158.10 +15.2% $1.27 $1,160 +16.0%
3 months $172.84 +5.3% $1.27 $1,061 +6.1%
6 months $141.24 +28.9% $2.54 $1,307 +30.7%
1 year $114.77 +58.6% $4.94 $1,629 +62.9%
2 years $128.86 +41.3% $9.59 $1,487 +48.7%
3 years $89.10 +104.3% $13.89 $2,199 +119.9%
5 years $75.32 +141.7% $21.64 $2,705 +170.5%

Historical returns from market close data. Past performance does not guarantee future results.

The Ledger's Promise

This entry now belongs to the ledger. Whatever PSX does next, these words stay.

Phillips 66 · PSX · Distribution · $242.71
Recorded 2026-11-19 · before the outcome · scored mechanically

Membership

Thirteen thousand names carry this page. One desk keeps them honest.

Membership opens the full screen archive, the composites built from it, and the daily coverage that prices what the screen approves.

Join the desk

Screening is research, not a fatwa and not financial advice. Figures are drawn from public accounts at the screen date shown. Always manage your risk.

Get our weekly market brief free.